A clinical trial to study the effect of nebulized lignocaine and ketamine in reducing incidence ofpostoperative sore throat
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/10/037492
- Lead Sponsor
- Department of Anaesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with American Society of Anesthesiologists (ASA) class I or class II physical
status.
Exclusion Criteria
1. Patient refusal ,
2. Pateints with ASA physical status III & IV,
3. History of allergic reactions to local anaesthetics or ketamine,
4. Patient with anticipated difficult intubation,
5. Duration of intubation more than 30s or more than 1 attempt of intubation,
6. Patients undergoing oral, head and neck surgeries,
7. Duration of surgery > 2hr
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence and severity of sore throat in first 24 <br/ ><br>hours of post operative periodTimepoint: Sore throat monitoring and grading will be done <br/ ><br>at 0,1, 2, 4, 8, 12, 16 and 24 hours post-extubation by <br/ ><br>an anaesthetist not aware of the group of patients
- Secondary Outcome Measures
Name Time Method To report any complication or side effect due to nebulization of lignocaine and ketamine if seenTimepoint: Monitoring will be done at 0, 2, 4, 8, 12, and 24 <br/ ><br>hours post-extubation by an anaesthetist.